SINOVAC BIOTECH LTD
(SVA)Financial Statements · SEC EDGAR XBRL
Revenue
$386.0M
+6.8%
EPS
$-0.83
-165.4%
Gross Margin
67.9%
Op. Income
-$490.1M
+3.0%
FCF
-$561.1M
-267.1%
Source: SEC EDGAR XBRL
Breakdown
Revenues
Revenues
Total Revenues
Cost of Revenues
Gross Profit
Operating Expenses & Income
Selling General & Admin
Research & Development
Total Operating Expenses
Operating Income
Non-Operating Income/Expense
Other Non-Operating Income
Pre-Tax Income
Income Tax Expense
Net Income
EPS (Basic)
EPS (Diluted)
Shares Outstanding (Diluted)